Navigation Links
Artificial disc brings increased mobility and rapid recovery to patients suffering chronic neck pain in the Midwest

KANSAS CITY, Mo., Nov. 15, 2012 /PRNewswire-USNewswire/ -- For many years cervical fusion was the only surgical option for patients suffering from chronic neck pain or single cervical disc degeneration.  The recent creation and approval of artificial discs have offered patients a new treatment option which allows greater mobility and range of motion and dramatically improved recovery times.  However, these initial artificial discs utilized hardware such as screws and pins.

On Nov. 13, 2012, H. Dennis Mollman, M.D., Ph.D. of Saint Luke's Neuroscience Institute of Kansas City, performed the first Bryan Disc surgery in Missouri, Kansas and Iowa, offering patients in the Midwest a new option for dealing with chronic neck pain. The Bryan Disc is an artificial cervical disc replacement which requires no hardware and can simply slide in and replace the patient's damaged natural disc.

"In the past cervical fusion was the standard treatment option," said Dr. Mollman, "Fusing the bones together limited range of motion and generally required a three month recovery as we waited for the bones to grow together.  The Bryan Disc allows patients to retain or regain range of motion and most are back to their normal activities within two weeks, a vastly improved recovery time."

As opposed to a lengthy cervical fusion surgery of four to six hours, the Bryan Disc surgery takes approximately 45 minutes. Patients generally leave the hospital the next day.  According to Dr. Mollman, these factors, coupled with the fact the Bryan Disc more closely resembles the patient's own natural disc, make it an appealing treatment option for patients considering cervical fusion or disc replacement.

More information about Dr. Mollman and the Bryan Disc can be found at and respectively.

About the Saint Luke's Neuroscience Institute

Saint Luke's Neuroscience Institute, a member of Saint Luke's Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of acute strokes. Its legacy of innovation began in 1993 when doctors performed one of the world's first intra-arterial stroke reversal procedures. Since then, Saint Luke's specialists have continued to pioneer new stroke therapies and reverse stroke's debilitating effects for thousands of patients, and is one of the world's most experienced and prolific leaders in the use of tPA, a clot-busting medication for treatment of acute ischemic stroke.   SLNI, headquartered in Kansas City,  brings together a team of the country's most accomplished neurologists to provide a comprehensive treatment center for the most complex neurological issues.

SOURCE Saint Luke's Health System
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 1st SynCardia Total Artificial Heart Patient Discharged from Ankara University in Turkey
2. Study Results of Artificial Disc Recipients Show Significant Improvement Compared to Pre-Surgery Condition
3. Global Artificial Implants Industry
4. Global Artificial Tears Industry
5. SynCardia Total Artificial Heart Patient Featured in U.S. News & World Reports "Best Hospitals" Issue
6. Global Artificial Organs Industry
7. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
8. 50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox
9. 1st SynCardia Total Artificial Heart Implant Performed in New England
10. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
11. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
Post Your Comments:
(Date:11/30/2015)... 2015 Booth #4303 – The Imaging Components business ... a broader array of products in a new booth (#4303) ... North America in Chicago ... feature X-ray components "At the Heart of Imaging." Products will ... from Varian,s Claymount brand, and computer-aided diagnostic software from MeVis ...
(Date:11/30/2015)... NAMUR , Belgium , Nov. 30, ... life sciences company focused on developing blood-based diagnostic tests for ... announced the Company will present at the LD Micro Conference, ... Los Angeles, CA. Attending from VolitionRx will ... and Scott Powell , Vice President of Investor Relations. ...
(Date:11/30/2015)... and REHOVOT, Israel , ... specialty pharmaceutical company focused on acquiring and developing innovative ... announced the appointment of Keith A. Katkin ... Gregory J. Flesher , chief executive officer for ... building successful organizations.  As chairman, he will be able ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... According to an article published November 13th by People ... to show her Instagram followers that the praise that they were bestowing on her ... she didn’t “want to mislead any mommy's who just had babies and are stressing,” ...
(Date:11/30/2015)... ... ... Cycling, running, and walking are regular Sunday activities for many South Floridians, ... 2016. , That’s when the 7th annual ANF Group Tour de Broward will ... families at Joe DiMaggio Children’s Hospital. , The community fundraiser, sponsored by ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one ... , Their study showed that small molecule analogs that target the functions of ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar ... and adults, according to a new study by researchers at the School of Public ... and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public ...
(Date:11/30/2015)... Pittsburgh, PA (PRWEB) , ... November 30, 2015 ... ... according to a new study by UPMC and KingMed Diagnostics ... UPMC over three years found that consultation with UPMC pathologists resulted in significantly ...
Breaking Medicine News(10 mins):